It was reported that CD133Neg glioma cells give rise to tumors in vivo as well as CD133Pos tumor cells and it was suggested that CD133 expression is needed for brain tumor initiation, however that it could be included during brain tumor progression (23). This evidence concerns the gene PROM1 and glioma.